Come up with a name for your new list and we'll add to it:
MacuLogix raised a round of funding on July 18, 2017. Investors include
Life Sciences Greenhouse of Central Pennsylvania.
MacuLogix is a provider in the early detection and tracking of age-related macular degeneration (AMD). MacuLogix' AdaptDx has received FDA 510(k) clearance for measurement of dark adaptation function …